Last reviewed · How we verify

Morphine, Parecoxib — Competitive Intelligence Brief

Morphine, Parecoxib (Morphine, Parecoxib) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Opioid analgesic combined with selective COX-2 inhibitor. Area: Pain Management.

marketed Opioid analgesic combined with selective COX-2 inhibitor Mu-opioid receptor (morphine); COX-2 enzyme (parecoxib) Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

Morphine, Parecoxib (Morphine, Parecoxib) — Pfizer. This is a combination of morphine (an opioid mu-receptor agonist) and parecoxib (a selective COX-2 inhibitor) that provides analgesia through both opioid and anti-inflammatory pathways.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Morphine, Parecoxib TARGET Morphine, Parecoxib Pfizer marketed Opioid analgesic combined with selective COX-2 inhibitor Mu-opioid receptor (morphine); COX-2 enzyme (parecoxib)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Opioid analgesic combined with selective COX-2 inhibitor class)

  1. Pfizer · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Morphine, Parecoxib — Competitive Intelligence Brief. https://druglandscape.com/ci/morphine-parecoxib. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: